// App-Quantinova.ai

: Recombinant human (rh)IGF-1/rhIGFBP-3 for prevention of bronchopulmonary dysplasia

Researchers

Presenter

  • Carlo Dani

Principal Investigators

  • Ingrid Hansen-Pupp

  • Olachi J. Mezu-Ndubuisi

  • Luca Ramenghi

  • Carmen Giannantonio

  • Peter Reynolds

  • Ajit Mahaveer

  • Jason D. Higginson

  • Chiara Poggi

  • Mohamed Hamdani

  • Alexandra Mangili

  • Adina Tocoian

  • Emily Jochim

  • Norman Barton

  • David Ley

  • Boubou Hallberg

  • Ann Hellstrm

Medical Centers

  • Ospedale Careggi, University of Florence, Florence, Italy

  • Lund University, Skåne University Hospital, Institute of Clinical Sciences Lund, Lund, Sweden

  • Departments of Pediatrics and Ophthalmology, University of Wisconsin, Madison, United States of America

  • Istituto Giannina Gaslini, Genoa, Italy

  • Division of Rheumatology, Fondazione Policlinico Universitario A. Gemelli, Catholic University of the Sacred Heart, Rome, Italy

  • NICU St Peter’s Hospital, Chertsey, Surrey, United Kingdom

  • St Mary’s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre and Division of Developmental Biology & Medicine, School of Medical Sciences, University of Manchester, Manchester, United Kingdom

  • Gastroenterology, East carolina University, Greenville, North Carolina, United States

  • Shire, Lexington, Massachusetts, United States of America

  • Shire GmbH, Zug, Switzerland

  • Department of ENT, Karolinska Institutet/Karolinska University Hospital, Stockholm, Sweden

  • Institute of Neuroscience and Physiology, Sahlgrenska Academy, Gothenburg, Sweden

Locations

  • Italy

  • Sweden

  • United States

  • United Kingdom

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Infant Respiratory Distress Syndrome

Biomarkers

  • Insulin-like growth factor 1

Drug/Treatment

  • Mecasermin rinfabate

Outcome

  • N/A


Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A